Search Results

Your search for Vishal Bhatnagar, MD,Vishal Bhatnagar, MD matches 2 pages

Showing 1 - 2

By Vishal Bhatnagar, MD; Bellinda King-Kallimanis, PhD; Paul Kluetz, MD; Heidi Klepin, MD; and Kathryn Mileham, MD / November 25, 2020

This Year’s FDA-ASCO Workshop Focused on Collection of Patient-Reported Tolerability Data From Clinical Trials

OCE Insights is an occasional column developed for The ASCO Post by members of the Oncology Center of Excellence (OCE) at the U.S. Food and Drug Administration (FDA). In this installment, Vishal Bhatnagar, MD, Associate Director for Patient Outcomes, Bellinda King-Kallimanis, PhD, Senior Staff...

issues in oncology

By The ASCO Post Staff / September 25, 2019

Patient-Centered Initiatives at the FDA

OCE Insights is a periodic column developed for The ASCO Post by members of the Oncology Center of Excellence (OCE) at the U.S. Food and Drug Administration (FDA). In this first installment, Vishal Bhatnagar, MD, Acting Associate Director of Patient Outcomes; Bellinda King-Kallimanis, PhD, Senior...

Nov

Today In Oncology

Search Results

Your search for Vishal Bhatnagar, MD,Vishal Bhatnagar, MD matches 2 pages

This Year’s FDA-ASCO Workshop Focused on Collection of Patient-Reported Tolerability Data From Clinical Trials

Patient-Centered Initiatives at the FDA

What Is the Impact of a Colon or Colorectal Cancer Diagnosis on Younger Adults?

International Cancer Organizations Present Collaborative Work During Oncology Event in China

Is There a Role for Neoadjuvant Chemotherapy in HR-Positive, HER2-Negative Early Breast Cancer?

Suicide-Related Mortality in Male AYA Cancer Survivors

Four-Year Asian Subpopulation Data From the CheckMate 816 Trial of Neoadjuvant Nivolumab Plus Chemotherapy in Resectable NSCLC